Orion Corporation

From Wikipedia, the free encyclopedia
Jump to navigation Jump to search
Orion Oyj
Julkinen osakeyhtiö
Traded as Nasdaq HelsinkiORNBV
Industry Pharmaceutical industry
Founded 1917; 101 years ago (1917)
Headquarters Espoo, Finland
Key people
Timo Lappalainen (President and CEO), Hannu Syrjänen (Chairman)
Products Pharmaceuticals, active pharmaceutical ingredients and diagnostic tests
Revenue Increase €1.074 billion (2016)
Increase €315 million (2016)
Increase €249 million (2016)
Total assets Increase €1.063 billion (2016)
Total equity Increase €641 million (2016)
Number of employees
Increase 3,446 (2016)
Website www.orion.fi
Footnotes / references

Orion Corporation, founded in 1917 and headquartered at Espoo, Finland, is a Finnish company, which develops, manufactures and markets pharmaceuticals, active pharmaceutical ingredients and diagnostic tests for global markets. The company also has a large R&D unit in Turku.

Orion's class A and B shares are listed on the Helsinki Stock Exchange.


  • Cardiovascular drugs


External links[edit]